UBTECH, a Shenzhen-based intelligent humanoid robots maker, raises $820M Series C led by Tencent, bringing the startup's valuation to about $5B
Context & Ripple Effects
UBTECH's $820M Series C made it one of the most richly capitalized humanoid robot makers of its generation, with Tencent leading at a ~$5B valuation while the company was still pre-commercial. The bet has since matured into shipped product: UBTech signed deals to sell its Walker S2 humanoids to Airbus and Texas Instruments and targets 10K units of production in 2026.
The round also seeded a broader pattern. Alibaba-backed X Square Robot, SF Group-backed Robotera, and Pudu Robotics have all since raised large rounds, turning Shenzhen and Beijing into a crowded, state-of-competition field rather than a one-company story.
First-order effects
- Tencent converts capital into a strategic position in embodied AI hardware, while UBTech gains the balance sheet to fund humanoid R&D and manufacturing ahead of any revenue base.
Second-order effects
- Rival backers respond in kind — Alibaba leads X Square Robot's ~$100M round and SF Group leads Robotera's $200M+ raise — making lead-investor identity a competitive signal among Chinese humanoid startups.
- Capital intensity spills into talent: UBTech's search for a chief scientist at up to ~$18M a year breaks from China's norm against mega pay packages, forcing peers to compete on compensation.
Third-order effects
- If the pattern holds, Chinese humanoid robotics consolidates around a handful of platform companies each anchored by an internet giant, with commercial deployments like the Walker S2 sales to Airbus and Texas Instruments deciding which of the funded players survives the capital race.
The trend: Chinese humanoid robotics is scaling from one-off mega-rounds into a giant-backed capital race where funding size, talent packages, and early industrial customers determine the survivors.